Equicoxib

Firocoxib

Firocoxib

COX-2 selective NSAID veterinary drug

Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox).[2][4][8] Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[9] Firocoxib is not intended or approved for use in human medicine.[2][4][5][6][10]

Quick Facts Clinical data, Trade names ...

Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004,[11] and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.[12][13]

Firocoxib is also available as a generic medication for horses[13] and for dogs.[11]

References

  1. [1]
    "Product information". Health Canada. 22 October 2009. Retrieved 9 February 2024.
  2. [2]
    "Equioxx- firocoxib tablet, chewable". DailyMed. 14 July 2020. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  3. [3]
    "Equioxx- firocoxib paste". DailyMed. 24 February 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  4. [4]
    "Previcox- firocoxib tablet, chewable". DailyMed. 23 July 2020. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  5. [5]
    "Equioxx EPAR". European Medicines Agency (EMA). Archived from the original on 25 April 2022. Retrieved 2 August 2022.
  6. [6]
    "Previcox EPAR". European Medicines Agency (EMA). Archived from the original on 31 July 2021. Retrieved 2 August 2022.
  7. [7]
    "Coxatab EPAR". European Medicines Agency (EMA). 17 June 2022. Retrieved 9 February 2024.
  8. [8]
    Rangel-Nava A, Ramírez-Uribe JM, Recillas-Morales S, Ibancovichi-Camarillo JA, Venebra-Muñoz A, Sánchez-Aparicio P (June 2019). "Pharmacological Regulation in the USA and Pharmacokinetics Parameters of Firocoxib, a Highly Selective Cox-2, by Pain Management in Horses". Journal of Equine Veterinary Science. 77: 36–42. doi:10.1016/j.jevs.2019.02.007. PMID 31133314. S2CID 86530623.
  9. [9]
    "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse. 2 July 2007. Archived from the original on 18 May 2011. Retrieved 18 April 2008.
  10. [10]
    Equioxx Archived 21 December 2014 at the Wayback Machine, European Medicines Agency (EMA)
  11. [11]
    "FDA Approves the First Generic Firocoxib Tablets for Dogs". U.S. Food and Drug Administration. 7 June 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.
  12. [12]
    "Merial launches first firocoxib for horses". DVM 360. 1 July 2007. Retrieved 3 October 2023.
  13. [13]
    "FDA Approves the First Generic Firocoxib Tablets for Horses". U.S. Food and Drug Administration (FDA). 1 August 2022. Archived from the original on 3 August 2022. Retrieved 2 August 2022.


Stub icon

This veterinary medicine–related article is a stub. You can help Wikipedia by expanding it.

Stub icon

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Equicoxib, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.